The Aster DM Healthcare board’s approval of the GCC separation deal is fairly valued, as anticipated, and is expected to enhance Aster’s presence in India through dedicated resources, fundraising, and expansion initiatives, indicated sector analysts. Additionally, the deal, analysts said, should strengthen the company’s balance sheet by reducing debt with the dividend payout remaining a key factor.
Shares of Aster DM Healthcare climbed over 12 per cent intraday on Wednesday after the company on November 28 informed the bourses of…